Last reviewed · How we verify
AG-707
At a glance
| Generic name | AG-707 |
|---|---|
| Sponsor | Agenus Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes (PHASE2)
- Trial Evaluating Safety, Tolerability and Immune Response of AG-707 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |